-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOVIE ANNOUNCES FULL ENROLLMENT OF THE ADDRESS-LC TRIAL OF BEZISTERIM FOR THE TREATMENT OF NEUROLOGICAL SYMPTOMS ASSOCIATED WITH LONG COVID

Reuters·05/26/2026 12:00:01

Please log in to view news